State Medicaid Pharmacy & Therapeutics Committee Meeting
Notice Tags
Medicaid, Pharmacies
Notice Type(s)
Meeting
Event Start Date & Time
December 19, 2013 07:00 AM
Event End Date & Time
December 19, 2013 08:30 AM
Event Deadline Date & Time
12/12/13 06:00 PM
Description/Agenda
UTAH DEPARTMENT OF HEALTH
STATE MEDICAID PHARMACY AND THERAPEUTICS COMMITTEE
Thursday, December 19, 2013
7:00 a.m. to 8:30 a.m.
Cannon Health Building
Room 128
AGENDA
Please note that persons who wish to address the P&T Committee may contact Lisa V. Hunt (lvhunt@utah.gov) at least 7 calendar days prior to the meeting. Comments from visitors, while welcome, may be limited due to time constraints
1) Welcome and Introductions.........................................................................................Kort Delost, R.Ph., Chair
a) Review and Approval of Minutes
2) Update on PDL Administration…………................................................................ Lisa Hunt, R.Ph.
a) Housekeeping
3) DUR Board Update.........................................................................................................Robyn Seely, PharmD
4) Topical Immune-modulators Drug Class Review ...................................................... Melissa Archer, PharmD
Agents to include: Pimecrolimus (Elidel®); Tacrolimus (Protopic®)
a) Other States Report…………………………………………………………..….. Lisa Hunt, R.Ph.
b) Public Comment:
c) Board Discussion/Questions
d) Board Action.
5) Topical/Local Anesthetic Agents Drug Class Review................................................ Melissa Archer, PharmD
a) Other States Report…………………………………………………………..….. Lisa Hunt, R.Ph.
b) Public Comment:
c) Board Discussion/Questions
d) Board Action.
6) Next Meeting January 16, 2014 (Pediculoside Agents Drug Class Review)
7) Adjourned……………………………………………………………………........Kort Delost, R. Ph., Chair
Public comment that responds to the materials presented by the College of Pharmacy @University of Utah is most helpful. The foundation documents used for most reviews are prepared by the Oregon Evidence-based Practice Center or the University of Utah, College of Pharmacy, and are posted in advance on the P&T Committee website. Manufacturers are requested to submit any additional materials they would like reviewed as part of the process to:
Dr. Gary Oderda
College of Pharmacy
30 South 2000 East
SLC, UT 84112-5820
All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible) after the Oregon monograph was prepared, unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search.
Month Topic Agents
12/19/2013 Topical Immune-modulators Drug Class Review Pimecrolimus (Elidel®); Tacrolimus (Protopic®)
Topical/Local Anesthetic Agents Drug Class Review Articaine, Benzocaine, Benzydamine, Benzyl Alcohol, Bupivacaine, Capsaicin, Cetylpyridinium, Chloroprocaine, Dibucaine, Dyclonine, Ethyl Chloride, Hexylresorcinol, Lidocaine, Mepivacaine, Pramoxine, Prilocaine, Proparacaine, Ropivacaine, Tetracaine, Trolamine, Zucapsaicin
1/16/2014 Pediculoside Agents Drug Class Review Benzyl Alcohol, Ivermectin, Lindane, Malathion, Permethrin, Pyrethrins and Piperonyl Butoxide, Spinosad
2/20/2014 Short Acting Opioid Agents Short-acting Agents
3/20/2014 Immediate Acting Opioid Agents Immediate-acting Agents
Notice of Special Accommodations (ADA)
NOTICE OF SPECIAL ACCOMMODATION DURING PUBLIC MEETINGS
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Lisa Hunt at 801-538-6317.